Integrative multi-omics reveals that downregulation of HLA-DPA1/DPB1 drives macrophage immune-metabolic dysregulation in pediatric asthma - Report - MDSpire

Integrative multi-omics reveals that downregulation of HLA-DPA1/DPB1 drives macrophage immune-metabolic dysregulation in pediatric asthma

  • By

  • Yuchen Wen

  • Zefan Du

  • Zhiyuan Zhong

  • Qiurong Yuan

  • Liangkang Lin

  • Ran Yao

  • Jiaying He

  • Qionghui Huang

  • Liang Li

  • Cheng Ouyang

  • Junbing Huang

  • Su Liu

  • Chun Chen

  • June 3, 2026

  • 0 min

Share

Clinical Report: HLA-DPA1/DPB1 Downregulation in Pediatric Asthma

Overview

This study identifies HLA-DPA1 and HLA-DPB1 downregulation as significant factors in macrophage immune-metabolic dysregulation in pediatric asthma. The findings suggest these genes may serve as potential biomarkers and therapeutic targets.

Background

Pediatric asthma is a common chronic respiratory condition with significant morbidity. Understanding the molecular mechanisms underlying immune dysfunction is crucial for developing targeted therapies. This study explores the role of specific immune checkpoint-related genes in the pathogenesis of pediatric asthma.

Data Highlights

GeneExpression ChangeDiagnostic Value
HLA-DPA1DownregulatedHigh
HLA-DPB1DownregulatedHigh

Key Findings

  • HLA-DPA1 and HLA-DPB1 were identified as candidate key genes in pediatric asthma.
  • Both genes were significantly downregulated in patients with pediatric asthma.
  • Downregulation correlated with impaired antigen presentation and metabolic dysfunction.
  • IL-13 stimulation confirmed reduced expression of these genes in bronchial epithelial cells.
  • Single-cell analysis revealed enrichment of these genes in a specific macrophage subset.

Clinical Implications

The identification of HLA-DPA1 and HLA-DPB1 as key genes in pediatric asthma highlights the importance of macrophage function in disease pathogenesis. These findings may inform future diagnostic and therapeutic strategies aimed at restoring immune balance in affected children.

Conclusion

This study provides new insights into the immune-metabolic dysregulation in pediatric asthma, emphasizing the potential of HLA-DPA1 and HLA-DPB1 as targets for future research and therapeutic intervention.

Related Resources & Content

  1. Frontiers in Pediatrics, 2026 -- Multi-omics integration reveals BPGM downregulation and potential plasma metabolite biomarkers for childhood asthma
  2. Frontiers in Immunology, 2026 -- miRNA profiling shows shared signatures in pediatric asthma, obesity and their comorbidity
  3. Frontiers in Immunology, 2026 -- Paradoxical enrichment of Akkermansia in children with poorly controlled asthma: a longitudinal study
  4. Frontiers in Immunology, 2026 -- Metabolic reprogramming of glutamine is associated with M2 macrophage polarization in allergic rhinitis
  5. 2026 GINA Strategy Report - Global Initiative for Asthma - GINA
  6. Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE) - PubMed
  7. Airway macrophage glycolysis controls lung homeostasis and responses to aeroallergen - PubMed
  8. 2026 GINA Strategy Report - Global Initiative for Asthma - GINA
  9. Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE) - PubMed
  10. Airway macrophage glycolysis controls lung homeostasis and responses to aeroallergen - PubMed

Original Source(s)

Integrative multi-omics reveals that downregulation of HLA-DPA1/DPB1 drives macrophage immune-metabolic dysregulation in pediatric asthma

  • by Yuchen Wen, Zefan Du, Zhiyuan Zhong, Qiurong Yuan, Liangkang Lin, Ran Yao, Jiaying He, Qionghui Huang, Liang Li, Cheng Ouyang, Junbing Huang, Su Liu, Chun Chen

  • June 3, 2026

Related Content

Paradoxical enrichment of Akkermansia in children with poorly controlled asthma: a longitudinal study

Association between a four-locus gene model including IL13, IL4, FCER1B, and ADRB2 and asthma outcomes

Global Initiative for Asthma Updates for Diagnosing Asthma in Adults